Artwork

Content provided by CHI Podcasts and Cambridge Healthtech Podcasts. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by CHI Podcasts and Cambridge Healthtech Podcasts or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://player.fm/legal.
Player FM - Podcast App
Go offline with the Player FM app!

Molecular Diagnostics Europe 2018 | Cell-Based NIPD: Where Are We Now and Where Are We Going?

4:15
 
Share
 

Manage episode 198017229 series 31038
Content provided by CHI Podcasts and Cambridge Healthtech Podcasts. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by CHI Podcasts and Cambridge Healthtech Podcasts or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://player.fm/legal.
Patrizia Paterlini-Brechot spoke to CHI to discuss her work in cell-based non-invasive prenatal diagnosis and some of the challenges in commercializing this technique. She also discusses the impact commercialized NIPD tests will have on the field of prenatal diagnosis and some of the new frontiers she expects will be next. Dr. Paterlini-Brechot is speaking at the Advances in prenatal Molecular Diagnostics meeting, part of Molecular Diagnostics Europe, taking place 22-24 May 2018 in Lisbon, Portugal For more information, please visit http://www.MolecularDXEurope.com/Prenatal-Dx/
  continue reading

255 episodes

Artwork
iconShare
 
Manage episode 198017229 series 31038
Content provided by CHI Podcasts and Cambridge Healthtech Podcasts. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by CHI Podcasts and Cambridge Healthtech Podcasts or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://player.fm/legal.
Patrizia Paterlini-Brechot spoke to CHI to discuss her work in cell-based non-invasive prenatal diagnosis and some of the challenges in commercializing this technique. She also discusses the impact commercialized NIPD tests will have on the field of prenatal diagnosis and some of the new frontiers she expects will be next. Dr. Paterlini-Brechot is speaking at the Advances in prenatal Molecular Diagnostics meeting, part of Molecular Diagnostics Europe, taking place 22-24 May 2018 in Lisbon, Portugal For more information, please visit http://www.MolecularDXEurope.com/Prenatal-Dx/
  continue reading

255 episodes

All episodes

×
 
Loading …

Welcome to Player FM!

Player FM is scanning the web for high-quality podcasts for you to enjoy right now. It's the best podcast app and works on Android, iPhone, and the web. Signup to sync subscriptions across devices.

 

Quick Reference Guide